More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$9.27B
EPS
4.05
P/E ratio
19
Price to sales
3.19
Dividend yield
--
Beta
0.97843
Previous close
$70.50
Today's open
$70.25
Day's range
$69.49 - $70.93
52 week range
$69.49 - $101.40
show more
CEO
Keith Pfeil
Employees
6000
Headquarters
AUDUBON, PA
Exchange
New York Stock Exchange
Shares outstanding
132471693
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Globus Medical, Inc. (GMED) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Globus Medical, Inc. (GMED) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • 10 hours ago

Globus Medical to Participate in Jefferies Global Healthcare Conference
AUDUBON, Pa., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Jefferies Global Healthcare Conference in London.
GlobeNewsWire • Nov 9, 2026

Globus Medical Q3 Earnings Call Highlights
Globus Medical NYSE: GMED lowered its 2026 revenue forecast after third-quarter sales fell, citing continued declines at its Nevro business, delayed spine product launches and lower contributions from competitive sales recruiting.
MarketBeat • Nov 7, 2026

GMED Q3 Earnings Call Highlights Guidance Cut and 2027 Reset
Globus Medical cuts its 2026 revenue outlook amid spine launch delays and weak Nevro sales while shifting its focus to new products and growth opportunities in 2027.
Zacks Investment Research • Nov 6, 2026

Globus Medical, Inc. (GMED) Q3 2026 Earnings Call Transcript
Globus Medical, Inc. (GMED) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 6, 2026

Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program
AUDUBON, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the third quarter ended September 30, 2026.
GlobeNewsWire • Nov 5, 2026

Compared to Estimates, Globus Medical (GMED) Q3 Earnings: A Look at Key Metrics
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Nov 6, 2026

Globus Medical (GMED) Q3 Earnings Top Estimates
Globus Medical (GMED) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.18 per share a year ago.
Zacks Investment Research • Nov 5, 2026

Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 2, 2026

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet
The consensus price target hints at a 30.5% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • Nov 2, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Globus Medical Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.